These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34556429)

  • 21. Using an online nominal group technique to determine key implementation factors for COVID-19 vaccination programmes in community pharmacies.
    Michel DE; Iqbal A; Faehrmann L; Tadić I; Paulino E; Chen TF; Moullin JC
    Int J Clin Pharm; 2021 Dec; 43(6):1705-1717. PubMed ID: 34633625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expanded practice in rural community pharmacy: a macro-, meso and micro-level perspective.
    Taylor S; Cairns A; Glass B
    Rural Remote Health; 2021 Jul; 21(3):6158. PubMed ID: 34304577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient Care in Community Pharmacies during the COVID-19 (SARS-CoV-2) Pandemic: Effectiveness of Post-Graduate Education and Further Training Courses on Revenues.
    Baratta F; Folpini E; Ciccolella M; Brusa P
    Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36900788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attitudes and availability: A comparison of naloxone dispensing across chain and independent pharmacies in rural and urban areas in Alabama.
    Sisson ML; McMahan KB; Chichester KR; Galbraith JW; Cropsey KL
    Int J Drug Policy; 2019 Dec; 74():229-235. PubMed ID: 31698165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19: How Can Rural Community Pharmacies Respond to the Outbreak?
    Adunlin G; Murphy PZ; Manis M
    J Rural Health; 2021 Jan; 37(1):153-155. PubMed ID: 32277726
    [No Abstract]   [Full Text] [Related]  

  • 27. Developing sustainable workflows for community pharmacy-based SARS-CoV-2 testing.
    O'Connor SK; Healey P; Mark N; Adams JL; Robinson R; Nguyen E
    J Am Pharm Assoc (2003); 2022; 62(1):253-259. PubMed ID: 34535408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harder to get than you think: Levonorgestrel emergency contraception access in West Virginia community pharmacies.
    Ashcraft AM; Farjo S; Ponte CD; Dotson S; Sambamoorthi U; Murray PJ
    J Am Pharm Assoc (2003); 2020; 60(6):969-977. PubMed ID: 32830066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community pharmacy during the COVID-19 pandemic: a cross-sectional study.
    Merks P; Świeczkowski D; Bilmin K; Jakubowska M; Drelich E; Lewicki J; Gołębiewska W; Bogusz J; Jaguszewski M
    Przegl Epidemiol; 2020; 74(4):620-633. PubMed ID: 33861029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rural pharmacists and stakeholders perspectives of expanded pharmacy practice: A descriptive study.
    Taylor SM; Cairns A; Glass BD
    Aust J Rural Health; 2021 Jun; 29(3):341-353. PubMed ID: 34148266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locations of COVID-19 vaccination provision: Urban-rural differences.
    Ryan GW; Kahl AR; Callaghan D; Kintigh B; Askelson NM
    J Rural Health; 2024 Jun; 40(3):476-482. PubMed ID: 37957524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Community Pharmacists Roles During the COVID-19 Pandemic.
    Hess K; Bach A; Won K; Seed SM
    J Pharm Pract; 2022 Jun; 35(3):469-476. PubMed ID: 33317371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Illustrating access to community pharmacies in Wisconsin.
    Look KA; Dekeyser C; Conjurske S; Platta M; Bohnen C; Black P; Portillo E
    J Am Pharm Assoc (2003); 2021; 61(4):492-499. PubMed ID: 33707122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventive counselling for public health in pharmacies in South Germany.
    Schmiedel K; Schlager H; Dörje F
    Int J Clin Pharm; 2013 Feb; 35(1):138-44. PubMed ID: 23129420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strengthening pandemic preparedness through pharmacy and public health collaborations: Findings from a facilitated discussion exercise.
    Bacci JL; Odegard P; Arnold J; Stergachis A
    J Am Pharm Assoc (2003); 2021; 61(3):e99-e106. PubMed ID: 33478926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies.
    Chen L; Lim J; Jeong A; Apollonio DE
    J Am Pharm Assoc (2003); 2020; 60(6):963-968.e2. PubMed ID: 32800456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating pharmacies into public health program planning for pandemic influenza vaccine response.
    Fitzgerald TJ; Kang Y; Bridges CB; Talbert T; Vagi SJ; Lamont B; Graitcer SB
    Vaccine; 2016 Nov; 34(46):5643-5648. PubMed ID: 27686834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using Health Insurance Network Provider Data and Public Data Sets to Identify SARS-CoV-2 Vaccinators in the USA.
    Litaker JR; Tamez N; Durkalski W; Taylor R
    Front Public Health; 2020; 8():616140. PubMed ID: 33585386
    [No Abstract]   [Full Text] [Related]  

  • 40. Pandemic preparedness of community pharmacies for COVID-19.
    Bahlol M; Dewey RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.